Shares of Amgen fell 1.57% to $227.62 at 11:39 EST on Friday, following yesterday’s upward trend. The Nasdaq Stock Market is falling 0.26% to $12,731.30, after four consecutive sessions in a row of gains. This seems, so far, a somewhat rough trend trading session today.
Amgen’s last close was $231.24, 16.41% under its 52-week high of $264.97.
Amgen’s sales growth is 6.4% for the present quarter and 3.3% for the next. The company’s growth estimates for the current quarter is a negative 6.3% and positive 1% for the next.
Year-on-year quarterly revenue growth grew by 12%, now sitting on 24.99B for the twelve trailing months.
Amgen’s Stock Yearly Top and Bottom Value
Amgen’s stock is valued at $227.62 at 11:39 EST, way under its 52-week high of $264.97 and way above its 52-week low of $177.05.
Amgen’s Moving Average
Amgen’s value is below its 50-day moving average of $228.10 and below its 200-day moving average of $238.25.
Previous days news about Amgen
Stocks making the biggest moves after the bell: Roku, Amgen & more. According to CNBC on Wed Dec 16, "Amgen – Amgen climbed 0.3% after the biotech company raised its quarterly dividend to $1.76 per share from $1.60 per share."